谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

An Open-Label, Multicenter Phase 1 Study to Characterize Safety, Tolerability, Preliminary Antitumor Activity, Pharmacokinetics, and Pharmacodynamics of VIP943 Monotherapy in Patients with Advanced CD123+ Hematologic Malignancies.

Stephen Anthony Strickland, Emily K. Curran, Omer Hassan Jamy, Mary-Elizabeth Percival,Amy J. Johnson,Joseph Birkett,Xin Huang,Melanie M. Frigault, Hans-Georg Lerchen,Beatrix Stelte-Ludwig,Tasheda Navarro, Jim Peck, Wyatt Gross,Raquel Izumi, Ahmed M. Hamdy,Naval Guastad Daver

Journal of Clinical Oncology（2024）

引用 0|浏览2
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要